Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
about
The water-soluble inclusion complex of ilexgenin A with β-cyclodextrin polymer--a novel lipid-lowering drug candidate.A porphyrin/β-cyclodextrin conjugated nano-system having a pan-lid molecular structure for smart drug carrier applications.Cyclodextrin-based pharmaceutics: past, present and future.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.Improved oral bioavailability of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol using nanoemulsion based on phospholipid complex: design, characterization, and in vivo pharmacokinetics in rats.Cyclodextrin-based hydrogels toward improved wound dressings.Liposome-containing polymer films and colloidal assemblies towards biomedical applications.Supramolecular cyclodextrin-based drug nanocarriers.Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.The role of L-arginine in inclusion complexes of omeprazole with cyclodextrinsCarbohydrate-Based Host-Guest Complexation of Hydrophobic Antibiotics for the Enhancement of Antibacterial Activity.Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin.Improved antifungal activity of itraconazole-loaded PEG/PLA nanoparticles.In vivo lifetime and anti-cancer efficacy of doxorubicin-loaded nanogels composed of cinnamoyl poly (β-cyclodextrin) and cinnamoyl Pluronic F127.Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.Liposome solubilization induced by complexation with dimeric β-cyclodextrin
P2860
Q30650408-74725B63-588C-4A07-994A-3783D2573CE5Q30808283-C94C4729-5E9F-4362-B2CE-4020E4054562Q34552997-CB46A3D7-9945-4AE2-9279-5D0628950567Q34733812-31337937-4229-4275-8CB4-1998F93D8D2CQ36161028-3BDA39CD-E4CD-4442-81B4-EB9CE6ED595CQ36636481-FE92BB4F-9D0F-4784-8AAF-52A065412692Q36917923-8B7F709C-ED0A-4D74-98E5-B291962B7D76Q37412939-22CA51DD-7BD8-4A2E-A825-63C850E97BC0Q38126910-E09E460E-B8B8-49F4-B6BD-5D09ED6B6F54Q38210999-F545BA19-7202-40A2-9819-55D149083E60Q38354545-C4F8D730-E5C3-4477-8D02-E0EED95F4DDAQ39212810-5B3C8B66-B99A-4690-A702-AD3B115727A7Q39923600-B37C6E0C-F801-44A6-AB41-8E1B3E5DBFBAQ40102211-6B502AC4-E15A-4146-A3B4-A618BBEC317DQ45953245-75364FD3-5E0F-4DEB-AC06-C260EB04545CQ46173569-70D6D9DF-2024-4F63-95BA-97A7BBCE8524Q47261975-03F175BC-AC25-4B65-B0E0-CF823987E96CQ51047817-5C9964F7-6051-4296-93F0-30F657546F2AQ53268665-BD4DBE89-2BE4-450A-AACE-DFA0546A9008Q58211576-4C86659D-5153-4F8F-AC2B-1B9661A00AF4
P2860
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@ast
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@en
type
label
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@ast
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@en
prefLabel
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@ast
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@en
P2093
P1476
Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
@en
P2093
Huining Xiao
Jianshu Li
YinPing Zhong
P304
P356
10.1016/J.IJPHARM.2004.03.026
P407
P577
2004-07-01T00:00:00Z